Maze Therapeutics (MAZE) Interest & Investment Income (2024 - 2026)

Maze Therapeutics (MAZE) has 3 years of Interest & Investment Income data on file, last reported at $3.2 million in Q1 2026.

• For the quarter ending Q1 2026, Interest & Investment Income rose 22.79% year-over-year to $3.2 million; the trailing twelve-month figure through Mar 2026 stood at $12.4 million (up 77.09% YoY), and the FY2025 full-year result was $11.8 million, up 153.09% from the prior year.
• Interest & Investment Income fell to $3.2 million in Q1 2026, from $3.5 million in the prior quarter.
• In the past five years, Interest & Investment Income ranged from a high of $3.5 million in Q4 2025 to a low of $281000.0 in Q1 2024.
• A 3-year average of $2.2 million and a median of $2.6 million in 2025 frame the typical range for Interest & Investment Income.
• Across the five-year window, Interest & Investment Income surged 830.6% in 2025 and climbed 22.79% in 2026, its largest moves.
• Tracing MAZE's Interest & Investment Income over 3 years: stood at $1.5 million in 2024, then soared by 130.28% to $3.5 million in 2025, then slipped by 8.02% to $3.2 million in 2026.
• Business Quant data shows MAZE's Interest & Investment Income at $3.2 million in Q1 2026, $3.5 million in Q4 2025, and $2.9 million in Q3 2025.